Goldman Sachs’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3M | Buy |
3,934,002
+1,209,563
| +44% | +$4.4M | ﹤0.01% | 2005 |
|
|
2025
Q1 | $5.23M | Buy |
2,724,439
+1,722,245
| +172% | +$3.31M | ﹤0.01% | 2710 |
|
|
2024
Q4 | $1.9M | Buy |
1,002,194
+516,925
| +107% | +$982K | ﹤0.01% | 3509 |
|
|
2024
Q3 | $641K | Buy |
485,269
+136,351
| +39% | +$180K | ﹤0.01% | 3989 |
|
|
2024
Q2 | $356K | Sell |
348,918
-1,064,735
| -75% | -$1.09M | ﹤0.01% | 4121 |
|
|
2024
Q1 | $2.59M | Buy |
1,413,653
+1,342,452
| +1,885% | +$2.46M | ﹤0.01% | 3036 |
|
|
2023
Q4 | $4.83M | Buy |
+71,201
| New | +$4.83M | ﹤0.01% | 2619 |
|
|
2023
Q3 | – | Sell |
-18,273
| Closed | -$16.7K | – | 4721 |
|
|
2023
Q2 | $16.7K | Sell |
18,273
-49,571
| -73% | -$45.4K | ﹤0.01% | 4769 |
|
|
2023
Q1 | $38K | Buy |
67,844
+52,516
| +343% | +$29.4K | ﹤0.01% | 4803 |
|
|
2022
Q4 | $8.84K | Sell |
15,328
-448,482
| -97% | -$259K | ﹤0.01% | 4953 |
|
|
2022
Q3 | $147K | Buy |
463,810
+122,264
| +36% | +$38.8K | ﹤0.01% | 4819 |
|
|
2022
Q2 | $0 | Sell |
341,546
-559,421
| -62% | – | ﹤0.01% | 5675 |
|
|
2022
Q1 | $647K | Sell |
900,967
-1,246,196
| -58% | -$895K | ﹤0.01% | 4419 |
|
|
2021
Q4 | $4.85M | Buy |
2,147,163
+1,632,905
| +318% | +$3.69M | ﹤0.01% | 2826 |
|
|
2021
Q3 | $1.48M | Sell |
514,258
-2,593,278
| -83% | -$7.47M | ﹤0.01% | 3709 |
|
|
2021
Q2 | $11.8M | Buy |
3,107,536
+328,849
| +12% | +$1.25M | ﹤0.01% | 2136 |
|
|
2021
Q1 | $9.41M | Sell |
2,778,687
-823,475
| -23% | -$2.79M | ﹤0.01% | 2247 |
|
|
2020
Q4 | $10.1M | Buy |
3,602,162
+2,150,016
| +148% | +$6.02M | ﹤0.01% | 2054 |
|
|
2020
Q3 | $3.65M | Buy |
1,452,146
+314,613
| +28% | +$790K | ﹤0.01% | 2572 |
|
|
2020
Q2 | $15.4M | Buy |
1,137,533
+365,281
| +47% | +$4.96M | ﹤0.01% | 1643 |
|
|
2020
Q1 | $5.85M | Buy |
772,252
+23,866
| +3% | +$181K | ﹤0.01% | 2146 |
|
|
2019
Q4 | $4.73M | Buy |
748,386
+439,972
| +143% | +$2.78M | ﹤0.01% | 2470 |
|
|
2019
Q3 | $1.21M | Buy |
308,414
+53,468
| +21% | +$210K | ﹤0.01% | 3145 |
|
|
2019
Q2 | $1.23M | Sell |
254,946
-106,327
| -29% | -$515K | ﹤0.01% | 3068 |
|
|
2019
Q1 | $2.96M | Sell |
361,273
-7,230
| -2% | -$59.2K | ﹤0.01% | 2719 |
|
|
2018
Q4 | $2.04M | Buy |
368,503
+244,878
| +198% | +$1.35M | ﹤0.01% | 2796 |
|
|
2018
Q3 | $1.09M | Sell |
123,625
-184,354
| -60% | -$1.63M | ﹤0.01% | 3160 |
|
|
2018
Q2 | $3.07M | Sell |
307,979
-473,478
| -61% | -$4.73M | ﹤0.01% | 2663 |
|
|
2018
Q1 | $7.45M | Buy |
781,457
+97,537
| +14% | +$930K | ﹤0.01% | 2109 |
|
|
2017
Q4 | $10.2M | Buy |
683,920
+43,923
| +7% | +$653K | ﹤0.01% | 1903 |
|
|
2017
Q3 | $12.6M | Buy |
639,997
+348,107
| +119% | +$6.85M | ﹤0.01% | 1851 |
|
|
2017
Q2 | $4.2M | Buy |
291,890
+242,613
| +492% | +$3.49M | ﹤0.01% | 2371 |
|
|
2017
Q1 | $453K | Buy |
49,277
+608
| +1% | +$5.59K | ﹤0.01% | 3561 |
|
|
2016
Q4 | $507K | Buy |
48,669
+30,513
| +168% | +$318K | ﹤0.01% | 3450 |
|
|
2016
Q3 | $164K | Buy |
18,156
+4,376
| +32% | +$39.5K | ﹤0.01% | 4012 |
|
|
2016
Q2 | $103K | Sell |
13,780
-447
| -3% | -$3.34K | ﹤0.01% | 4115 |
|
|
2016
Q1 | $128K | Buy |
14,227
+2,616
| +23% | +$23.5K | ﹤0.01% | 3952 |
|
|
2015
Q4 | $150K | Buy |
+11,611
| New | +$150K | ﹤0.01% | 3848 |
|
|
2015
Q3 | – | Sell |
-17,616
| Closed | -$181K | – | 4548 |
|
|
2015
Q2 | $181K | Buy |
+17,616
| New | +$181K | ﹤0.01% | 4061 |
|